phrykt

Repligen Corp (RGEN): who owns it and who trades it

As of Nov 16, 2026, RGEN insiders reported 13 open-market sales worth $8.2M and no purchases in the last 12 months, with 72% of the sale value made under pre-set 10b5-1 plans. The largest seller was Olivier Loeillot (CEO), with $7.7M. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Repligen

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns RGEN

475 funds and institutions reported RGEN shares worth $9B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 9.5%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.9.5%
FMR LLC (Fidelity)5.9%
United Capital Financial Advisors, LLC4.9%
Vanguard Capital Management LLC4.3%
Vanguard Portfolio Management LLC4.1%
Maverick Capital Ltd3.5%
State Street Corp3.2%
T. Rowe Price Associates3.1%
Massachusetts Financial Services Co2.9%
Wasatch Advisors LP2.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.5.38M9.55%$735M-10%
FMR LLC (Fidelity)3.33M5.90%$454M+15%
United Capital Financial Advisors, LLC2.79M4.95%$381M+1%
Vanguard Capital Management LLC2.41M4.27%$329M+1%
Vanguard Portfolio Management LLC2.31M4.10%$316M+0%
Maverick Capital Ltd1.98M3.52%$271M+31%
State Street Corp1.80M3.19%$246M+1%
T. Rowe Price Associates1.75M3.11%$239M-64%
Massachusetts Financial Services Co1.62M2.87%$221M+16%
Wasatch Advisors LP1.59M2.82%$217M+28%
Ameriprise Financial Inc1.58M2.79%$215M+70%
Bank of New York Mellon Corp1.52M2.70%$208M-1%
T. Rowe Price Investment Management, Inc.1.41M2.50%$193M+3%
Invesco Ltd.1.39M2.46%$189M+9%
Holocene Advisors, LP1.29M2.29%$176M+82%
Rtw Investments, LP1.24M2.20%$169M+3%
Geode Capital Management, LLC1.06M1.88%$145M-0%
Congress Asset Management Co1.01M1.79%$138M+27%
Conestoga Capital Advisors, LLC980,9831.74%$134M-11%
Goldman Sachs Group Inc965,4111.71%$132M+48%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, RGEN insiders reported $0 of open-market purchases and $8.2M of sales. 72% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$8.2M
13 trades, 4 people
Sales under a 10b5-1 plan
72%
Share of sale value
Latest trade
Oct 5, 2026
Filed Oct 6, 2026

Purchases and sales by month

$3.9M$3.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 5, 2026Olivier LoeillotCEOSale plan1,333$178.75$238KForm 4
Oct 5, 2026Olivier LoeillotCEOSale plan4,202$190.00$798KForm 4
Sep 24, 2026Olivier LoeillotCEOSale plan8,404$190.00$1.6MForm 4
Sep 24, 2026Olivier LoeillotCEOSale plan4,542$190.00$863KForm 4
Sep 21, 2026Olivier LoeillotCEOSale plan5,426$180.00$977KForm 4
Sep 4, 2026Olivier LoeillotCEOSale plan3,035$165.90$504KForm 4
Aug 20, 2026Olivier LoeillotCEOSale plan5,426$180.00$977KForm 4
Jul 16, 2026Jason K GarlandCFOSale530$150.00$79.5KForm 4
Jun 25, 2026Jason K GarlandCFOSale733$145.00$106KForm 4
Apr 21, 2026Olivier LoeillotCEOSale3,832$140.00$536KForm 4
Dec 17, 2025Karen A DawesDirectorSale275$161.00$44.3KForm 4
Nov 25, 2025Olivier LoeillotCEOSale7,041$170.00$1.2MForm 4
Nov 18, 2025James BylundChief Operating OfficerSale2,191$151.21$331KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Olivier LoeillotChief Executive Officer, Director–$7.7MOct 5, 2026
James BylundChief Operating Officer–$331KNov 18, 2025
Jason K GarlandCFO–$186KJul 16, 2026
Karen A DawesDirector–$44.3KDec 17, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

RGEN short interest

High short interest. 11.0% of RGEN shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 24%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.05M RGEN shares were sold short, 11.0% of the shares outstanding, down 1.3% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 4.9 trading days (days to cover).

Shares short, % of all shares

11.0%May 15Oct 3013.9%

Days to cover

4.9May 15Oct 308.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.05M11.04%-1%1.45M4.9
Oct 15, 20267.15M12.66%-6%1.46M4.9
Sep 30, 20267.58M13.43%+13%1.15M6.6
Sep 15, 20266.71M11.89%+2%947,1887.1
Aug 31, 20266.61M11.72%+9%990,2646.7
Aug 14, 20266.09M10.78%-1%944,6706.4
Jul 31, 20266.13M10.87%+6%1.56M3.9
Jul 15, 20265.81M10.30%-4%732,4477.9
Jun 30, 20266.05M10.72%+6%1.30M4.7
Jun 15, 20265.73M10.15%-4%900,2716.4
May 29, 20265.96M10.57%+5%1.22M4.9
May 15, 20265.70M10.10%+4%1.47M3.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded RGEN

Since Nov 17, 2024, 2 members of Congress reported 3 purchases and 4 sales of RGEN. The latest was a sale by Lisa C. McClain on Oct 31, 2025, reported Nov 21, 2025.

Purchases 3Sales 4

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Jul 22, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Lisa C. McClain (R-MI)Partial sale$1K–$15KSpouseAug 13, 2025Report
Jun 11, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Apr 7, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfMay 8, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Repligen company events

Repligen filed 12 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 6, 2026.

  1. Nov 6, 2026AgreementIn connection with the consummation of previously announced private exchange and subscription transactions, Repligen Corporation issued $1.0 billion of its 0.25% Convertible Senior Notes due 2031 under an Indenture, dated November 6, 2026, between the Company and U.S. Bank Trust Company, National… Filing
  2. Oct 30, 2026AnnouncementOf this Current Report on Form 8-K is incorporated herein by reference. Filing
  3. Oct 27, 2026ResultsReleased financial results. Filing
  4. Oct 6, 2026DealThe information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. Filing
  5. Sep 15, 2026LeadershipKaren A. Dawes notified Repligen Corporation that she will be retiring from the Repligen Board of Directors after over twenty years of distinguished service to Repligen, effective as of September 30, 2026. Filing
  6. Sep 8, 2026AnnouncementAs previously disclosed, on July 21, 2026, Repligen Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger with Bravo Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Repligen, Bravo Merger Sub II, LLC, a Delaware limited liability company and… Filing
  7. Jul 28, 2026ResultsReleased financial results. Filing
  8. Jul 22, 2026AgreementRepligen Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger by and among Repligen, Bravo Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Repligen, Bravo Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of… Filing
  9. May 15, 2026VoteReported shareholder vote results. Filing
  10. May 5, 2026ResultsReleased financial results. Filing
  11. Feb 24, 2026ResultsReleased financial results. Filing
  12. Jan 6, 2026LeadershipRepligen Corporation announced that the Board of Directors has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Repligen financials

Famous investors that hold RGEN

6 of the 50 well-known investors we track reported holding RGEN in their latest 13F filing. The largest position is Lee Ainslie's, worth $272M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Lee Ainslie · Maverick CapitalQ3 20261.42M$272M2.2%-29%
Andreas Halvorsen · Viking Global InvestorsQ3 2026531,227$102M0.3%New
Ken Griffin · Citadel AdvisorsQ3 2026263,824$50.7M0.0%-30%
Steve Cohen · Point72 Asset ManagementQ3 2026241,982$46.5M0.1%+46%
Ray Dalio · Bridgewater AssociatesQ3 202689,106$17.1M0.1%New
Stanley Druckenmiller · Duquesne Family OfficeQ3 202677,400$14.9M0.4%No change

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named RGEN in the last 120 days.

FiledHolderFormStake
Oct 7, 2026FMR LLC13G/A13.0%
Oct 7, 2026FMR LLC13G/A13.0%

Questions about Repligen Corp (RGEN) stock

Who owns the most RGEN stock?

The largest reported owner of Repligen Corp (RGEN) is BlackRock, Inc., with 9.5% of the company. In total, 475 funds and institutions reported holding RGEN at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are RGEN insiders buying or selling?

In the last 12 months, RGEN insiders reported no open-market purchases and 13 sales worth $8.2M. The latest trade was on Oct 5, 2026. See every trade.

What is the short interest in RGEN?

As of Oct 30, 2026, 7.05M RGEN shares were sold short, 11.0% of the shares outstanding, down 1.3% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 4.9 trading days (days to cover). See the history.

Have members of Congress traded RGEN?

Yes. 2 members of Congress reported 3 purchases and 4 sales of RGEN since Nov 17, 2024. The latest was reported on Nov 21, 2025. See the trades.

Which famous investors hold RGEN?

6 of the 50 well-known investors we track reported RGEN in their latest 13F filing, including Lee Ainslie, Andreas Halvorsen, Ken Griffin. The largest position is worth $272M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.